Clorox Stocks Gain Amid Analyst Optimism and Dividend Strength
Mar 25, 2026, 3:26 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
Base valuation analysis indicates an attractive entry point for investors, while dividend stability adds to the appeal. Historical precedence shows that despite temporary cost pressures, long-term fundamentals can support price recovery.
AI summary
What happened, with direct paths to the underlying reporting
Clorox's stock is seeing positive movement as it is deemed undervalued by analysts, trading at just 16x earnings. The company's solid dividend yield and expectations for earnings growth contribute to its appeal, even amidst rising input costs, which are expected to be temporary in nature.
Clorox shares are gaining traction as they appear undervalued.
The stock trades at 16x earnings versus a historical range of 18x to 30x.
Clorox offers a 4.9% dividend yield, raised for 24 consecutive years.
Rising input costs impacting margins are expected to be temporary.
Analysts currently provide a consensus hold rating with modest price targets.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
Clorox forecast annual sales above analysts' expectations, citing stronger health and wellness demand and international markets despite macro uncertainty. The upbeat guidance sugg…
Clorox is slated to release Q4 results after the market close on Aug 3, with consensus EPS of $1.65 on $1.91B revenue, a significant YoY decline from $2.87 and $1.99B. The modest…
Clorox rose after confirming Chris Hyder as COO on June 17, signaling a leadership-driven strategy shift. The market also noted Clorox’s roughly 5% dividend yield, cited by Gilman…
Clorox has reported mixed Q3 results, with flat revenue but a 1% decline in organic sales. The company adjusted its EPS guidance downwards and projects a 6% revenue decline in fis…